Didier Jean

2.6k total citations
50 papers, 1.7k citations indexed

About

Didier Jean is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Oncology. According to data from OpenAlex, Didier Jean has authored 50 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Pulmonary and Respiratory Medicine, 16 papers in Molecular Biology and 12 papers in Oncology. Recurrent topics in Didier Jean's work include Occupational and environmental lung diseases (24 papers), Protease and Inhibitor Mechanisms (8 papers) and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (7 papers). Didier Jean is often cited by papers focused on Occupational and environmental lung diseases (24 papers), Protease and Inhibitor Mechanisms (8 papers) and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (7 papers). Didier Jean collaborates with scholars based in France, United States and Switzerland. Didier Jean's co-authors include Menashe Bar‐Eli, Raymond Frade, Marie‐Claude Jaurand, Ze’ev A. Ronai, Nathalie Rousselet, Françoise Le Pimpec‐Barthes, David J. McConkey, Mario Luca, Matthew T. Harbison and Françoise Galateau-Sallé and has published in prestigious journals such as Journal of Biological Chemistry, Nature Communications and Cancer Research.

In The Last Decade

Didier Jean

49 papers receiving 1.7k citations

Peers

Countries citing papers authored by Didier Jean

Since Specialization

Citations

This map shows the geographic impact of Didier Jean's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Didier Jean with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Didier Jean more than expected).

Fields of papers citing papers by Didier Jean

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Didier Jean. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Didier Jean. The network helps show where Didier Jean may publish in the future.

Co-authorship network of co-authors of Didier Jean

This figure shows the co-authorship network connecting the top 25 collaborators of Didier Jean. A scholar is included among the top collaborators of Didier Jean based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Didier Jean. Didier Jean is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	The impact of Charcot-Leyden Crystal protein on mesothelioma chemotherapy: targeting eosinophils for enhanced chemosensitivity 2024 ·EBioMedicine ·(unknown), Malik Hamaïdia, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Yves Brostaux, (unknown), Renaud Louis, Bernard Duysinx, Didier Jean, (unknown), Arnaud Scherpereel, Christophe Blanquart, Luc Willems	4
2	Deep dive into the immune response against murine mesothelioma permits design of novel anti-mesothelioma therapeutics 2023 ·Frontiers in Immunology ·(unknown), Stefano Caruso, Clément Meiller, Inbal Mishalian, Théo Z. Hirsch, Quentin Bayard, Carmit T. Tadmor, Hanna Wald, Didier Jean, Ori Wald	2
3	Viral Mimicry Response Is Associated With Clinical Outcome in Pleural Mesothelioma 2022 ·JTO Clinical and Research Reports ·(unknown), Weihong Qi, Hubert Rehrauer, (unknown), (unknown), (unknown), Clément Meiller, Rolf A. Stahel, Martin Früh, Ferdinando Cerciello, Jean‐François Fonteneau, Didier Jean, Emanuela Felley‐Bosco	5
4	A Community-Driven, Openly Accessible Molecular Pathway Integrating Knowledge on Malignant Pleural Mesothelioma 2022 ·Frontiers in Oncology ·Marvin Martens, (unknown), Friederike Ehrhart, Didier Jean, (unknown), Holly M. Mortensen, (unknown), Penny Nymark, Chris T. Evelo, Ferdinando Cerciello	3
5	Combined MEK and PI3K/p110β Inhibition as a Novel Targeted Therapy for Malignant Mesothelioma Displaying Sarcomatoid Features 2020 ·Cancer Research ·Miriam Marqués, Robin Tranchant, (unknown), (unknown), Luis C. Fernández, Enrique Carrillo de Santa Pau, Natalia del Pozo, Jaime Martínez de Villarreal, Clément Meiller, Yves Allory, Yuna Blum, Christine Pirker, Balázs Hegedűs, Simon T. Barry, Amancio Carnero, Walter Berger, Didier Jean, Francisco X. Real	21
6	The Biology of Malignant Mesothelioma and the Relevance of Preclinical Models 2020 ·Frontiers in Oncology ·Christophe Blanquart, Marie‐Claude Jaurand, Didier Jean	25
7	Frequent Homozygous Deletions of Type I Interferon Genes in Pleural Mesothelioma Confer Sensitivity to Oncolytic Measles Virus 2020 ·Journal of Thoracic Oncology ·(unknown), (unknown), Nicolas Boisgerault, (unknown), (unknown), (unknown), Soizic Dutoit, Christophe Blanquart, Pierre‐Joseph Royer, Stéphane Minvielle, Lisa Quetel, Clément Meiller, Didier Jean, Delphine Fradin, Jaafar Bennouna, A. Magnan, L. Cellerin, Frédéric Tangy, Marc Grégoire, Jean‐François Fonteneau	38
8	Assessment of signaling pathway inhibitors and identification of predictive biomarkers in malignant pleural mesothelioma 2018 ·Lung Cancer ·Robin Tranchant, Lisa Quetel, François Montagne, Julien De Wolf, Clément Meiller, Leanne de Koning, Françoise Le Pimpec‐Barthes, Jessica Zucman‐Rossi, Marie‐Claude Jaurand, Didier Jean	10
9	Co-occurring Mutations of Tumor Suppressor Genes, LATS2 and NF2 , in Malignant Pleural Mesothelioma 2016 ·Clinical Cancer Research ·Robin Tranchant, Lisa Quetel, Anne Tallet, Clément Meiller, Annie Renier, Leanne de Koning, Aurélien de Reyniès, Françoise Le Pimpec‐Barthes, Jessica Zucman‐Rossi, Marie‐Claude Jaurand, Didier Jean	60
10	Molecular Classification of Malignant Pleural Mesothelioma: Identification of a Poor Prognosis Subgroup Linked to the Epithelial-to-Mesenchymal Transition 2014 ·Clinical Cancer Research ·Aurélien de Reyniès, Marie‐Claude Jaurand, Annie Renier, Gabrielle Couchy, Ilir Hysi, Nabila Elarouci, Françoise Galateau-Sallé, Marie‐Christine Copin, Paul Hofman, Aurélie Cazes, Pascal Andujar, Sandrine Imbeaud, Fabien Petel, Jean‐Claude Pairon, Françoise Le Pimpec‐Barthes, Jessica Zucman‐Rossi, Didier Jean	100
11	Molecular Changes in Mesothelioma With an Impact on Prognosis and Treatment 2012 ·Archives of Pathology & Laboratory Medicine ·Didier Jean, Julien Daubriac, Françoise Le Pimpec‐Barthes, Françoise Galateau-Sallé, Marie‐Claude Jaurand	73
12	Syntenic Relationships between Genomic Profiles of Fiber-Induced Murine and Human Malignant Mesothelioma 2011 ·American Journal Of Pathology ·Didier Jean, Emilie Thomas, Élodie Manié, Annie Renier, Aurélien de Reyniès, Céline Boulangé-Lecomte, Pascal Andujar, Jocelyne Fleury‐Feith, Françoise Galateau-Sallé, Marco Giovannini, Jessica Zucman‐Rossi, Marc‐Henri Stern, Marie‐Claude Jaurand	36
13	Down‐regulation of the expression of RB18A/MED1, a cofactor of transcription, triggers strong tumorigenic phenotype of human melanoma cells 2009 ·International Journal of Cancer ·Jean De La Croix Ndong, Didier Jean, Nathalie Rousselet, Raymond Frade	24
14	Intratumoral gene delivery of anti-cathepsin L single-chain variable fragment by lentiviral vector inhibits tumor progression induced by human melanoma cells 2008 ·Cancer Gene Therapy ·Raymond Frade, Nathalie Rousselet, Didier Jean	17
15	Activation of Epstein–Barr virus/C3d receptor (gp140, CR2, CD21) on human B lymphoma cell surface triggers Cbl tyrosine phosphorylation, its association with p85 subunit, Crk-L and Syk and its dissociation with Vav 2005 ·Cellular Signalling ·(unknown), Didier Jean, Muriel Le Romancer, Raymond Frade	12
16	Expression of cathepsin L in human tumor cells is under the control of distinct regulatory mechanisms 2005 ·Oncogene ·Didier Jean, Nathalie Rousselet, Raymond Frade	25
17	Vascular endothelial growth factor synthesis in the acute phase of experimental and clinical lung injury 2001 ·European Respiratory Journal ·Bernard Maître, S. Boussat, Didier Jean, (unknown), Laurent Brochard, B. Housset, Serge Adnot, Christophe Delclaux	89
18	Inhibition of tumor growth and metastasis of human melanoma by intracellular anti-ATF-1 single chain Fv fragment 2000 ·Oncogene ·Didier Jean, Carmen S. Tellez, Suyun Huang, Darren W. Davis, Christiane J. Bruns, David J. McConkey, Steven H. Hinrichs, Menashe Bar‐Eli	57
19	CREB and Its Associated Proteins Act as Survival Factors for Human Melanoma Cells 1998 ·Journal of Biological Chemistry ·Didier Jean, Matthew T. Harbison, David J. McConkey, Ze’ev A. Ronai, Menashe Bar‐Eli	141
20	Dominant-negative CREB inhibits tumor growth and metastasis of human melanoma cells 1997 ·Oncogene ·Shanhai Xie, Janet E. Price, Mario Luca, Didier Jean, Ze’ev A. Ronai, Menashe Bar‐Eli	103

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact